Epalrotokewali
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epalrotokewali, covering 2025-10-03 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma. [Phase 2]